QrumPharma acquired by MannKind Corp.

One of our longstanding clients, QrumPharma LLC based in Doylestown, PA, USA, has been acquired by MannKind Corporation just recently.

See full details in the press release here: https://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-expands-its-pipeline-acquisition-qrumpharma-inc

We are delighted that this project has come to such a huge success and thank the team at QrumPharma for the longstanding and very amicable cooperation. We wish all of you, but also of course the project for developing inhaled Clofazimine for the treatment of NTM, utmost success in the future!

Successful clinical development. Period.
Dyrhusvej 20, 6270 Tønder, Denmark